or Try an Advanced Search...

    Advanced Cancers Stocks List

    Symbol Grade Name % Change
    VSTM C Verastem, Inc. 0.00
    GMAB F Genmab A/S 0.00
    View As Page of Charts
    Related Industries: Biotechnology Long-Term Care Facilities
    Related Stock Lists: Advanced Cancer Cancer Medicine Acute Myeloid Leukemia Amyloid Amyloidosis Antibodies Antibody Drug Conjugate Biopharmaceutical Biotechnology Breakthrough Therapy Breast Cancer Camidanlumab Tesirine Cancer Research Cancer Stem Cell Cancer Stem Cells Cd20 Chronic Lymphocytic Leukemia Clinical Medicine Companion Diagnostic

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Cancers stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 3.22
    IBB D iShares Nasdaq Biotechnology Index Fund 1.66
    CNCR D Loncar Cancer Immunotherapy ETF 1.29
    WDNA D WisdomTree BioRevolution Fund 1.2
    GDOC C Goldman Sachs Future Health Care Equity ETF 0.77
    View all Advanced Cancers ETFs...
    Compare ETFs
    Compare CNCR to GDOC Compare CNCR to WDNA Compare FBT to IBB

        Advanced Cancers Stocks Recent News

        Date Stock Title
        May 26 VSTM Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
        May 26 VSTM Verastem: Narrowed Market And Less Compelling Efficacy Warrant Rating Downgrade
        May 24 VSTM Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
        May 24 VSTM What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
        May 24 VSTM Sector Update: Health Care Stocks Advance Pre-Bell Friday
        May 24 VSTM ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
        May 24 VSTM Verastem whipsaws after updates for cancer drug combo
        May 24 VSTM Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer
        May 24 VSTM Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
        May 23 VSTM Verastem stock rallies on positive data for pancreatic cancer drug combo
        May 23 VSTM Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer​
        May 23 GMAB Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
        May 22 GMAB Genmab acquires biotechnology company ProfoundBio in $1.8bn deal
        May 21 GMAB Genmab Completes Acquisition of ProfoundBio
        Related Industries: Biotechnology Long-Term Care Facilities
        Related Stock Lists: Advanced Cancer Cancer Medicine Acute Myeloid Leukemia Amyloid Amyloidosis Antibodies Antibody Drug Conjugate Biopharmaceutical Biotechnology Breakthrough Therapy Breast Cancer Camidanlumab Tesirine Cancer Research Cancer Stem Cell Cancer Stem Cells Cd20 Chronic Lymphocytic Leukemia Clinical Medicine Companion Diagnostic
        Advanced Cancers

        Advanced cancer is a term used to describe cancer that has spread from the original (primary) tumor to other parts of the body. It is also known as metastatic cancer. Advanced cancer is usually more difficult to treat than early-stage cancer.

        Browse All Tags